The novel approach of this peptide represents a significant advance in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide227821.blogcudinti.com/42092425/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment